Arbutus Biopharma Stock Price (NASDAQ:ABUS)

Add to My Stocks
$5.65 $0.1 (1.74%) ABUS stock closing price Feb 16, 2018 (Closing)
Prev Close* : $5.75
Market Cap:
$311.04M
Day Low: $5.55
52 Week Low: $2.55
Open: $5.7
Volume: -
Day High: $5.7
52 Week High: $8.25
Dividend:
0.00

Latest Stock Market News

Latest Articles

Arbutus Biopharma News - From Partners

ABUS Stockcharts

View ABUS PE ratio, PS ratio stocks charts and compare with peers.
ABUS Chart
Note: Compare Arbutus Biopharma stock price history with the index and industry peers.

Arbutus Biopharma Valuation

PE ratio
(price earnings ratio)
-999.0000
PS ratio (
price to sales ratio
)
39.51
PB ratio (
price to book ratio
)
1.36

Arbutus Biopharma Returns

ROE
(return on equity)
-116%

Arbutus Biopharma Financial Ratios

Asset Turnover
0.11
Receivables Turnover
3.44
Debt to Equity
0.08
Dividend Yield
0%

ABUS Industry Peers

Company Price Change (%)
Enzo Biochem (ENZ)6.890.09 (1.29%)
Celldex Therapeutics (CLDX)2.350.04 (1.73%)
Marina Biotech (MRNA)1.70.02 (1.19%)
Benitec Biopharma (BNTC)3.50.07 (1.96%)
Spectrum Pharma (SPPI)21.160.47 (2.17%)
Bristol-myers Squibb (BMY)68.960.02 (0.03%)
Bioasis Technologies (BIOAF)0.540.02 (3.57%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
Novavax (NVAX)2.340.18 (8.33%)
Fate Therapeutics (FATE)8.760.65 (8.01%)
Dicerna Pharma (DRNA)10.630.57 (5.67%)
Alkermes (ALKS)67.263.51 (5.51%)
AVID BIOSERVICS (CDMO)2.490.12 (5.06%)
Achillion Pharma (ACHN)3.20.13 (4.23%)
NewLink Genetics (NLNK)7.110.27 (3.95%)
Top gainers from Medical-Biomed-Genetics industry
* As of Feb 17, 2018
CompanyPriceChange (%)
Cytokinetics (CYTK)8.0250.63 (7.28%)
MiMedx (MDXG)14.470.96 (6.22%)
Catalyst Biosciences (CBIO)31.082.01 (6.07%)
Advaxis (ADXS)2.510.13 (4.92%)
Insmed (INSM)24.231.14 (4.49%)
Amicus Therapeutics (FOLD)15.170.66 (4.17%)
Alder BioPharma (ALDR)13.550.5 (3.56%)
Top losers from Medical-Biomed-Genetics industry
* As of Feb 17, 2018

Arbutus Biopharma Corp Stock News - Partner Headlines

Arbutus Biopharma Financial Statements

income statement20162015201420132012
Net Sales or Revenues1.49M24.87M14.95M15.46M14.1M
Net Income-384.16M-61.12M-38.83M-14.06M29.79M
Total Operating Expense493.11M127.18M47.39M26.99M26.16M
View Arbutus Biopharma income statement
balance sheet20162015201420132012
Total Assets275.91M712.29M118.17M71.71M52.32M
Total Liabilities72.91M164.61M30.14M12.52M11.61M
Shareholders Equity203M547.67M88.03M59.19M40.71M
View Arbutus Biopharma balance sheet
cash flow statement20162015201420132012
Net Increase (Decrease) in Assets Liabilities-0.46M-14.63M16.51M2.29M-2.43M
Net Cash from (used by) Operating Activities-57.88M-54.78M-12.42M-6.73M33.11M
Increase (Decrease) in Prop Plant And Equipment-3.97M-2.28M-0.97M-0.72M-0.01M
View Arbutus Biopharma cash flow statement

Arbutus Biopharma Stock Message Board

Arbutus Biopharma stock lost 1.74%, and the last close price as of Feb 16, 2018 is $5.65 for ABUS stock. Stock price or share price can be used to find the total market value of a company. Arbutus Biopharma market cap stands at $311.04M as of Feb 16, 2018. Arbutus Biopharma valuation can be guaged using various valuation metrics like the price to earnings ratio.

The terms stocks and shares mean the same thing. For Ex: Arbutus Biopharma stock price and Arbutus Biopharma share price mean the same thing. 101,901 shares were traded with a closing stock price of $5.65 as of Feb 16, 2018, as can be seen from Arbutus Biopharma stock quote. One can view Arbutus Biopharma stock chart to follow the stock price trend. A dividend is a cash payment made from a company's earnings and is distributed among shareholders. Arbutus Biopharma does not pay dividends. Arbutus Biopharma stock price history has details about historical stock quotes, P/E ratios and price to sales ratios.